Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157
Like sermorelin, tesamorelin binds to GHRH receptors in the pituitary gland to release growth hormone
Through its modulation of the NNMT-SAM-NAD+ axis, it enhances energy expenditure and supports more efficient utilization of fat stores for energy, making it a strong candidate in studies exploring metabolic optimization and obesity control
Patients are generally encouraged to follow provider recommendations regarding alcohol use, hydration, nutrition, exercise recovery, medications, and overall wellness habits while participating in a peptide therapy program
Depending on the situation, evaluation may include discussion of labs, inflammation, metabolic health, hormone balance, sleep, nutrient status, physical therapy, medication effects, or referral when appropriate